ArticleAmerican journal of surgery2026
Experiences and challenges of sexual and gender minority patients undergoing breast cancer treatment.
Article in American journal of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThis survey study sought to characterize the experiences and treatments of sexual and gender minority (SGM) patients with breast cancer.
methodsThe WhySurg survey was modified to focus on SGM patients and distributed via social media, support groups, and clinic flyers between 2023 and 2024. SGM individuals, age ≥18, and a history of breast cancer were eligible. Descriptive and reflexive thematic analyses were performed.
results50 individuals responded, with 31 (62%) completing it. Most (77%) were cisgender women, 16% nonbinary, and 3% transgender man. Most (58%) were lesbian/gay/homosexual, while 23% were bisexual, 13% pansexual, 13% queer, 3% asexual, 1 heterosexual, and 1 other. 29% experienced discrimination related to their SGM identity during treatment. Three themes emerged: 1) SGM identity influenced surgical choice, 2) respondents were reluctant to share SGM identity, and 3) appropriate surgical expectations are key to optimize gender-affirming patient-centered outcomes.
conclusionSGM data is essential to ensure patient-centered surgical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.